American immunologist and Nobel laureate (born 1948)
James Patrick Allison (born August 7, 1948)
[4] is an American
immunologist and
Nobel laureate who holds the position of
professor and chair of
immunology and executive director of
immunotherapy platform at the
MD Anderson Cancer Center at the
University of Texas .
His discoveries have led to
new cancer treatments for the deadliest cancers. He is also the director of the
Cancer Research Institute (CRI) scientific advisory council. He has a longstanding interest in mechanisms of
T-cell development and activation, the development of novel strategies for
tumor immunotherapy , and is recognized as one of the first people to isolate the
T-cell antigen receptor complex protein .
[5]
[6]
In 2014, he was awarded the
Breakthrough Prize in Life Sciences ; in 2018, he shared the
Nobel Prize in Physiology or Medicine with
Tasuku Honjo .
[7]
[8]
Early life
Allison was born on August 7, 1948, in
Alice, Texas , the youngest of three sons of Constance Kalula (Lynn) and Albert Murphy Allison.
[9] He was inspired by his eighth-grade math teacher to pursue a career in science, spending a summer in a
National Science Foundation –funded summer science-training program at the
University of Texas, Austin , and completing high-school biology by correspondence course at
Alice High School .
[10]
[11] Allison earned a
Bachelor of Science degree in
microbiology from
University of Texas, Austin , in 1969, where he was a member of
Delta Kappa Epsilon fraternity. He earned his
doctor of philosophy degree in
biological science in 1973, also from UT Austin, as a student of G. Barrie Kitto.
[12]
[13]
Career
From 1974 to 1977, Allison worked as
postdoctoral fellow at
Scripps Clinic and Research Foundation in
California . Then he worked as assistant biochemist and assistant professor at
MD Anderson to 1984.
[14] He was appointed a professor of immunology and director of the Cancer Research Laboratory at the
University of California, Berkeley in 1985 and was concurrently appointed professor at the
University of California, San Francisco from 1997.
[15]
In 2004, he moved to the
Memorial Sloan-Kettering Cancer Center (MSKCC) in
New York City to become the director of the Ludwig Center for Cancer Immunotherapy and the chair of the immunology program as well as the Koch chair in immunologic studies and attending immunologist at the Memorial Sloan-Kettering Cancer Center. He was a professor of
Weill Cornell Medicine and co-chair of the Department of Graduate Program in Immunology and Microbial Pathogenesis at
Weill Cornell Graduate School of Medical Sciences from 2004 to 2012, and also a
Howard Hughes Medical Institute (HHMI) investigator until 2012, when he left to join the M. D. Anderson Cancer Center in 2012. Since 2012 he has been chair of immunology at M.D. Anderson.
[14]
He is a member of the
National Academy of Sciences and the
National Academy of Medicine (formerly Institute of Medicine), and is a fellow of the
American Academy of Microbiology and the
American Association for the Advancement of Science . He is director of the
Cancer Research Institute scientific advisory council. Previously, he served as president of the
American Association of Immunologists .[
citation needed ] He is on the Research Advisory Board of Candel Therapeutics
[16] and Lytix Biopharma.
[17]
Allison serves as a commentator in the
Cancer documentary.
Research
Cancer Therapy by Inhibition of Negative Immune Regulation (CTLA4, PD1)
Allison trained at Scripps Research under tumor-immunologist Ralph Reisfeld, Ph.D., professor emeritus, researching human leukocyte antigens (HLA) and T-cells and exploring the role HLA proteins play in enabling the immune system to distinguish self from invaders. In 1977, Allison and a colleague, G. N. Callahan, reported in a letter to Nature that they had found evidence that the immune system was prevented from attacking cancer cells due to antigens’ association with additional proteins. Finding the factors that inhibited the immune attack on cancer has been key to developing checkpoint-blockade cancer immunotherapies.
[15]
In 1982, Allison first discovered the T-cell receptor.
[18] Allison's research to elucidate mechanisms of T-cell responses was conducted in the 1990s at the
University of California, Berkeley .
[19]
[20] In the early 1990s, James Allison showed that CTLA-4 acts as an inhibitory molecule to restrict T-cell responses. In 1996, Allison was the first to show that antibody blockade of a T-cell inhibitory molecule (known as
CTLA-4 ) could lead to enhanced anti-tumor immune responses and tumor rejection.
This concept of blocking T-cell inhibitory pathways as a way of unleashing anti-tumor immune responses and eliciting clinical benefit laid the foundation for the development of other drugs that target T-cell inhibitory pathways, which have been labeled as "
immune checkpoint therapies ".
[10] This work ultimately led to the clinical development of
ipilimumab (Yervoy), which was approved in 2011 by the FDA for the treatment of
metastatic melanoma .
[21]
Allison's research is in molecular immunology of the
T-cell antigen receptor complex , co-stimulatory receptors, and other molecules involved in T-cell activation. He is particularly interested in finding signals that lead to differentiation of
naive T-cells and also those that determine whether antigen receptor engagement will lead to functional activation or inactivation of T-cells. Once defined, the basic studies are used to develop new strategies for the treatment of
autoimmune diseases and
immunotherapy of
cancer . Most recently he has been interested in understanding the immune responses in cancer patients who respond to immunotherapy. He established the immunotherapy platform at MD Anderson Cancer Center to study immune responses in cancer patients.
[22]
Honors
According to a quantitative analysis, Allison was the top-ranking recipient of the most prestigious international science awards in the period 2010–2019, having received 13 of the top 40 such awards in any field of science.
[23]
In 2011 Allison won the
Jacob Heskel Gabbay Award for Biotechnology and Medicine
[24] and was awarded the
American Association of Immunologists Lifetime Achievement Award .
[25] In 2013 he shared the
Novartis Prize for Clinical Immunology . In 2014 he shared the first
Tang Prize in Biopharmaceutical Science with
Tasuku Honjo ,
[1] won the 9th Annual
Szent-Györgyi Prize for Progress in Cancer Research of the
National Foundation for Cancer Research , received the $3 million
Breakthrough Prize in Life Sciences , the
Canada Gairdner International Award ,
[26] the
Louisa Gross Horwitz Prize ,
[27] the
Massry Prize
[28] and the
Harvey Prize
[29] of the
Technion Institute of Technology in
Haifa . In 2015, he received the
Lasker-DeBakey Clinical Medical Research Award .
[2] and
Paul Ehrlich and Ludwig Darmstaedter Prize .
[30]
In 2017 he received the
Wolf Prize in Medicine ,
[31] the
Warren Alpert Foundation Prize
[32] and the
Balzan Prize for Immunological Approaches in Cancer Therapy (this prize jointly with
Robert D. Schreiber ).
[33] In 2018 he received the
King Faisal International Prize in Medicine,
[34] the
Jessie Stevenson Kovalenko Medal and the
Albany Medical Center Prize in Medicine and Biomedical Research.
[35]
He, along with
Tasuku Honjo , was jointly awarded the
Nobel Prize in Physiology or Medicine in 2018 for their discovery of cancer therapy by inhibition of negative immune regulation.
[36]
[37]
[38]
He is the subject of the 2019 documentary film "Jim Allison: Breakthrough" directed by Bill Haney.
[39] Allison received the Golden Plate Award of the
American Academy of Achievement in 2019.
[40]
Personal life
Allison married Malinda Bell in 1969. They have one son, Robert Allison, born in 1990, who is, as of 2018, an architect in New York City. Allison and Malinda lived separate lives for many years and eventually divorced in 2012. Allison met
Padmanee Sharma , MD, PhD through Dr. Lloyd Old in 2004. Allison and Sharma became collaborators and friends and married 10 years later in 2014. Allison is stepfather to Thalia Sharma Persaud, Avani Sharma Persaud and Kalyani Sharma Persaud.
[41]
Allison's mother died of
lymphoma
[15] when he was 10. His brother died of
prostate cancer in 2005.
He plays the
harmonica for a
blues band of
immunologists and
oncologists called the Checkpoints. He also plays with a local band called the Checkmates.
[41]
References
^
a
b
"First Tang Prize for Biopharmaceutical Science Awarded to James P. Allison, PhD, and Tasuku Honjo, MD, PhD" . www.tang-prize.org .
The ASCO Post . July 10, 2014. Retrieved August 4, 2016 .
^
a
b Foundation, Lasker.
"Unleashing the immune system to combat cancer | The Lasker Foundation" . The Lasker Foundation . Lasker Foundation. Retrieved August 4, 2016 .
^
"James Allison wins 2018 Dr. Paul Janssen Award for Biomedical Research" . Retrieved September 11, 2018 .
^
a
b
"James P. Allison – Facts – 2018" . NobelPrize.org . Nobel Media AB. October 1, 2018. Retrieved October 5, 2018 .
^
"James Allison" . Cancer Research Institute . Retrieved August 4, 2016 .
^ Blair, Jenny (May 2, 2014).
"Raising the Tail" .
The Alcalde .
Texas Exes . Retrieved October 3, 2018 .
^
"2014 Tang Prize in Biopharmaceutical Science" .
Archived from the original on October 20, 2017. Retrieved June 18, 2016 .
^ Devlin, Hannah (October 1, 2018).
"James P Allison and Tasuku Honjo win Nobel prize for medicine" . the Guardian . Retrieved October 1, 2018 .
^
"FamilySearch.org" .
FamilySearch . Retrieved December 5, 2023 .
^
a
b Cavallo, Jo (September 15, 2014).
"Immunotherapy Research of James P. Allison, PhD, Has Led to a Paradigm Shift in the Treatment of Cancer - The ASCO Post" . www.ascopost.com . ASCO Post. Retrieved August 4, 2016 .
^ Lopez, Monica (October 1, 2018).
"Alice native Dr. James Allison awarded 2018 Nobel Prize in Physiology or Medicine" . Corpus Christi Caller Times .
^ Barton, Jackson (October 2, 2018).
"Alumni receives Nobel Prize for revolutionary cancer treatment" . The Daily Texan. Archived from
the original on October 4, 2018. Retrieved October 3, 2018 .
^ Allison, James Patrick (1973).
Studies on bacterial asparaginases: I. Isolation and characterization of a tumor inhibitory asparaginase from Alcaligenes Eutrophus. II. Insolubilization of L-Asparaginase by covalent attachment to nylon tubing (Ph.D.).
The University of Texas at Austin .
OCLC
43380316 – via
ProQuest .
^
a
b
"James P. Allison, Ph.D. - Immunology - Faculty - MD Anderson Cancer Center" . faculty.mdanderson.org . Retrieved August 4, 2016 .
^
a
b
c
"Meet the Carousing Texan Who Just Won a Nobel Prize" . WIRED . Retrieved October 25, 2018 .
^
"James P. Allison PH.D." Candel Therapeutics . April 13, 2021. Retrieved September 27, 2021 .
^
"Advisory Board - Lytix Biopharma" . www.lytixbiopharma.com . Retrieved December 5, 2023 .
^ Allison, JP; McIntyre, BW; Bloch, D (November 1982).
"Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody" . Journal of Immunology . 129 (5): 2293–300.
doi :
10.4049/jimmunol.129.5.2293 .
PMID
6181166 .
S2CID
13249566 .
^ Leach, D. R.; Krummel, M. F.; Allison, J. P. (March 22, 1996). "Enhancement of Antitumor Immunity by CTLA-4 Blockade". Science . 271 (5256). American Association for the Advancement of Science (AAAS): 1734–1736.
Bibcode :
1996Sci...271.1734L .
doi :
10.1126/science.271.5256.1734 .
ISSN
0036-8075 .
PMID
8596936 .
S2CID
7215817 .
^
"UC Berkeley Cancer Research Lab » The Story of Yervoy (Ipilimumab)" . crl.berkeley.edu . Retrieved October 6, 2018 .
^ Dreifus, Claudia (February 3, 2020).
"The Contrarian Who Cures Cancers" . Quanta Magazine. Retrieved February 4, 2020 .
^
"James P. Allison - Researcher Profile | Memorial Sloan-Kettering Cancer Center" . Memorial Sloan - Kettering Cancer Center. Archived from
the original on January 6, 2013. Retrieved January 10, 2013 .
^ Meho, Lokman I. (2020).
"Highly prestigious international academic awards and their impact on university rankings" . Quantitative Science Studies : 1–25.
doi :
10.1162/qss_a_00045 .
S2CID
218488355 .
^
"Past winners" . brandeis.edu . Brandeis University. Retrieved October 1, 2018 .
^
"Past Recipients" . The American Association of Immunologists . Retrieved September 19, 2018 .
^ Ackerman, Todd (April 4, 2014).
"The scientist who just might cure cancer" . Houston Chronicle. Retrieved August 4, 2016 .
^
"Horwitz Prize Awarded for Work on Therapy That Uses the Immune System to Destroy Cancer Cells" . Cumc.columbia.edu. October 2, 2014. Retrieved October 1, 2018 .
^
"2014 Massry Prize recipients noted for work in immunotherapy" . hscnews dated August 19, 2014 . August 19, 2014. Retrieved October 8, 2020 .
^
Harvey Prize 2014
Archived July 2, 2015, at the
Wayback Machine
^
"Paul Ehrlich and Ludwig Darmstaedter prize for pioneer work in cancer immunotherapy" . eurekalert date March 15, 2015 . Retrieved October 8, 2020 .
^
"Wolf Prize to be awarded to eight laureates from US, UK and Switzerland" . Jpost.com. January 3, 2017. Retrieved October 1, 2018 .
^
"James Allison" . warrenalpert.org . Retrieved October 8, 2020 .
^
"Fondazione Balzan" . www.balzan.org . Archived from
the original on September 11, 2017. Retrieved September 11, 2017 .
^
"King Faisal International Prize 2018" . Kfip.org. April 1, 2018. Retrieved October 1, 2018 .
^
"Trailblazing Researchers in Immunotherapy Selected to Receive America's Most Distinguished Prize in Medicine" . Amc.edu. August 15, 2018. Retrieved October 1, 2018 .
^
"Discovery of cancer therapy by inhibition of negative immune regulation" (PDF) . The Nobel Assembly. Retrieved October 1, 2018 .
^ Hannah, Devlin (October 2018).
"James P Allison and Tasuku Honjo win Nobel prize for medicine" . The Guardian . Retrieved October 1, 2018 .
^
"All Nobel Prizes" . Nobel Foundation. Retrieved October 3, 2018 .
^
"Documentary Film | Jim Allison" . BREAKTHROUGH . Retrieved December 5, 2023 .
^
"Golden Plate Awardees of the American Academy of Achievement" . www.achievement.org .
American Academy of Achievement .
^
a
b Ackerman, Todd (December 30, 2015).
"For pioneering immunotherapy researcher, the work is far from over" . Houston Chronicle. Retrieved August 4, 2016 .
External links
1901–1925 1926–1950 1951–1975 1976–2000 2001–present
1970s 1980s 1990s 2000s 2010s 2020s
Mathematics
Fundamental physics
Nima Arkani-Hamed ,
Alan Guth ,
Alexei Kitaev ,
Maxim Kontsevich ,
Andrei Linde ,
Juan Maldacena ,
Nathan Seiberg ,
Ashoke Sen ,
Edward Witten (2012)
Special :
Stephen Hawking ,
Peter Jenni ,
Fabiola Gianotti (ATLAS),
Michel Della Negra ,
Tejinder Virdee ,
Guido Tonelli ,
Joseph Incandela (CMS) and
Lyn Evans (LHC) (2013)
Alexander Polyakov (2013)
Michael Green and
John Henry Schwarz (2014)
Saul Perlmutter and members of the
Supernova Cosmology Project ;
Brian Schmidt ,
Adam Riess and members of the
High-Z Supernova Team (2015)
Special :
Ronald Drever ,
Kip Thorne ,
Rainer Weiss and contributors to
LIGO project (2016)
Yifang Wang ,
Kam-Biu Luk and the
Daya Bay team ,
Atsuto Suzuki and the
KamLAND team,
Kōichirō Nishikawa and the
K2K /
T2K team,
Arthur B. McDonald and the
Sudbury Neutrino Observatory team,
Takaaki Kajita and
Yōichirō Suzuki and the
Super-Kamiokande team (2016)
Joseph Polchinski ,
Andrew Strominger ,
Cumrun Vafa (2017)
Charles L. Bennett ,
Gary Hinshaw ,
Norman Jarosik ,
Lyman Page Jr. ,
David Spergel (2018)
Special :
Jocelyn Bell Burnell (2018)
Charles Kane and
Eugene Mele (2019)
Special :
Sergio Ferrara ,
Daniel Z. Freedman ,
Peter van Nieuwenhuizen (2019)
The Event Horizon Telescope Collaboration (2020)
Eric Adelberger ,
Jens H. Gundlach and
Blayne Heckel (2021)
Special :
Steven Weinberg (2021)
Hidetoshi Katori and
Jun Ye (2022)
Charles H. Bennett ,
Gilles Brassard ,
David Deutsch ,
Peter W. Shor (2023)
John Cardy and
Alexander Zamolodchikov (2024)
Life sciences
Cornelia Bargmann ,
David Botstein ,
Lewis C. Cantley ,
Hans Clevers ,
Titia de Lange ,
Napoleone Ferrara ,
Eric Lander ,
Charles Sawyers ,
Robert Weinberg ,
Shinya Yamanaka and
Bert Vogelstein (2013)
James P. Allison ,
Mahlon DeLong ,
Michael N. Hall ,
Robert S. Langer ,
Richard P. Lifton and
Alexander Varshavsky (2014)
Alim Louis Benabid ,
Charles David Allis ,
Victor Ambros ,
Gary Ruvkun ,
Jennifer Doudna and
Emmanuelle Charpentier (2015)
Edward Boyden ,
Karl Deisseroth ,
John Hardy ,
Helen Hobbs and
Svante Pääbo (2016)
Stephen J. Elledge ,
Harry F. Noller ,
Roeland Nusse ,
Yoshinori Ohsumi ,
Huda Zoghbi (2017)
Joanne Chory ,
Peter Walter ,
Kazutoshi Mori ,
Kim Nasmyth ,
Don W. Cleveland (2018)
C. Frank Bennett and
Adrian R. Krainer ,
Angelika Amon ,
Xiaowei Zhuang ,
Zhijian Chen (2019)
Jeffrey M. Friedman ,
Franz-Ulrich Hartl ,
Arthur L. Horwich ,
David Julius ,
Virginia Man-Yee Lee (2020)
David Baker ,
Catherine Dulac ,
Dennis Lo ,
Richard J. Youle [
de ] (2021)
Jeffery W. Kelly ,
Katalin Karikó ,
Drew Weissman ,
Shankar Balasubramanian ,
David Klenerman and
Pascal Mayer (2022)
Clifford P. Brangwynne ,
Anthony A. Hyman ,
Demis Hassabis ,
John Jumper ,
Emmanuel Mignot ,
Masashi Yanagisawa (2023)
Carl June ,
Michel Sadelain ,
Sabine Hadida ,
Paul Negulescu ,
Fredrick Van Goor ,
Thomas Gasser ,
Ellen Sidransky and
Andrew Singleton (2024)
Sustainable Development Biopharmaceutical Science Sinology Rule of Law
International National Academics People Other